Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01936493 · ClinicalTrials.gov registry record
Biologic Predictors of Leiomyoma Treatment Outcomes
A clinical trial of Uterine Fibroids and Fibroids, sponsored by Elizabeth A. Stewart.
- Completed
- Registry status
- 38
- Enrollment target
- 1
- Study location
NCT01936493: Completed study of Uterine Fibroids and Fibroids, sponsored by Elizabeth A. Stewart.
NCT01936493 is a study of Uterine Fibroids and Fibroids that has completed, run by Elizabeth A. Stewart. The registered enrollment target is 38 participants, below the 240-participant average among 10 other Uterine Fibroids trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01936493, a study of Uterine Fibroids and Fibroids, has completed, sponsored by Elizabeth A. Stewart.
- COMPLETED
- Registry status
- 38 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to search for the hereditary (genetic) causes of uterine fibroids. Some women with uterine fibroids may have one or more genes that make them more likely to develop uterine fibroids. We are trying to identify these genes to better understand how and why uterine fibroids develop and to design better treatment options for women with uterine fibroids. This information may also help us to understand and treat other problems that may be caused by these genes.
Conditions Studied
Interventions
- GENETIC DNA analysis
- OTHER Hormonal analysis
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2009-08 |
| Est. Completion | 2015-05-26 |
What the finished NCT01936493 record still lists
NCT01936493 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 38 participants, a relatively small participant target, below the 240-participant average among 10 other Uterine Fibroids trials with a reported enrollment target (84% lower).
The record links to 4 conditions, with Uterine Fibroids appearing as the primary indexed condition, and to 2 interventions - of which DNA analysis is the first listed.
NCT01936493 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT01936493 about?
NCT01936493 is a clinical study titled "Biologic Predictors of Leiomyoma Treatment Outcomes". The purpose of this study is to search for the hereditary (genetic) causes of uterine fibroids. Some women with uterine fibroids may have one or more genes that make them more likely to develop uterine fibroids. We are trying to identify these genes to better understand how and why uterine fibroids ...
What is the current status of trial NCT01936493?
This trial is currently completed. The enrollment target is 38 participants. The study started on 2009-08. Estimated completion is 2015-05-26.
What conditions does trial NCT01936493 study?
This clinical trial studies the following conditions: Uterine Fibroids, Fibroids, Uterine Leiomyomas, Myomas.
What interventions are being tested in trial NCT01936493?
The interventions under investigation include: DNA analysis (GENETIC), Hormonal analysis (OTHER).
Who is sponsoring clinical trial NCT01936493?
This trial is sponsored by Elizabeth A. Stewart, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01936493 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Uterine Fibroids
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01936493's enrollment target sits among peer trials
38 8th of 10 higher than 3 of 10 other Uterine Fibroids trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Uterine Fibroids trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
An Open-Label Study to Evaluate the Effect of Elix Cycle Balance & Elix Daily Harmony on Fibroid-related Symptoms
RECRUITING · NA
-
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
RECRUITING · Phase 3
-
Effect of Addition of Steroids on Duration of Analgesia
ACTIVE NOT RECRUITING · Early Phase 1
-
Uterine Leiomyoma Treatment With Radiofrequency Ablation (ULTRA) Registry
ACTIVE NOT RECRUITING
-
Uterine Leiomyoma Treatment With Radiofrequency Ablation
COMPLETED · NA
-
Extension Study of Proellex in Women Who Have Previously Completed Study ZPU 003
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01684904 · 38 participants · NA
Proton Therapy for Esophageal Cancer
- NCT03310879 · 38 participants · Phase 2
Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6
- NCT03896269 · 38 participants · Phase 1
CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
- NCT04085315 · 38 participants · Phase 1
Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia